Bacterial urinary tract infection among adult renal transplant recipients at St. Paul's hospital millennium medical college, Addis Ababa, Ethiopia.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
31 07 2019
Historique:
received: 06 06 2019
accepted: 23 07 2019
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 24 11 2020
Statut: epublish

Résumé

Despite significant advances in surgical techniques, immunosuppression protocols, follow up periods and antimicrobial stewardship in modern medicine; post-renal transplantation urinary tract infection remained a major public health problem globally. This multiple serious squeals includes asymptomatic bacteriuria, cystitis and pyelonephritis. Among these, the bacterial origin of infection complications accounts for the most significant clinical, socio-economic impacts in many countries of the world. Therefore, the aim of the study was to investigate the prevalence of bacterial isolates that cause urinary tract infections, assess antibiotic susceptibility pattern among symptomatic and asymptomatic renal transplant recipients attending at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. A hospital-based cross-sectional study was conducted from December 2017 to August 2018 among 74 renal transplant recipients St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. A first morning voided clean-catch mid-stream urine specimens were collected and 0.001 ml inoculated onto blood and MacConkey agar plates following the standard bacteriological protocols. It was incubated aerobically at 35-37 °C for 24-48 h. Cultural characteristics and series of biochemical tests were used for the identification of isolates to species level based on the standard bacteriological protocols. A hospital-based cross-sectional study has shown that significant bacteriuria was found in 11/74 (14.9, 95% CI =8.2-24.7) patients. The prevalence among females 6/32 (18.75%) was higher among males 5/42 (11.9%) without significant association (COR = 2.09, 95% CI = 1.04-8.45, P = 0.253). Urinary tract infection was higher in the age group of 35-49 years old (19.3%). Age was statistically significant and stronger independent associated risk factor with crude odds ratio = 3.67, 95% CI = 2.89-20.07 and P = 0.003, respectively. The most prevalent bacteria isolates were Escherichia coli 2(18.2%), Staphylococcus aureus 2(18.2%), Acinetobacter spp. 2(18.2%), Enterococcus spp. 2(18.2%), Coagulase-negative Staphylococci 2(18.2%) followed by Porteus mirabilis 1(9.1%). The majority (80%) of Gram-negative bacteria were resistant to ciprofloxacin, chloramphenicol, and trimethoprim/sulfamethoxazole. Simultaneously, the multidrug-resistant bacterial isolates accounts for 82% among tested kidney allograft recipients. In conclusion, the overall prevalence of urinary tract infection in the study participants was relatively low with a prevalence of 14.9%. Majority of the study participants were asymptomatic and a higher percentage of females were involved. The multidrug-resistant bacterial isolates in the present study account for 82%.

Sections du résumé

BACKGROUND
Despite significant advances in surgical techniques, immunosuppression protocols, follow up periods and antimicrobial stewardship in modern medicine; post-renal transplantation urinary tract infection remained a major public health problem globally. This multiple serious squeals includes asymptomatic bacteriuria, cystitis and pyelonephritis. Among these, the bacterial origin of infection complications accounts for the most significant clinical, socio-economic impacts in many countries of the world. Therefore, the aim of the study was to investigate the prevalence of bacterial isolates that cause urinary tract infections, assess antibiotic susceptibility pattern among symptomatic and asymptomatic renal transplant recipients attending at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
METHODS
A hospital-based cross-sectional study was conducted from December 2017 to August 2018 among 74 renal transplant recipients St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. A first morning voided clean-catch mid-stream urine specimens were collected and 0.001 ml inoculated onto blood and MacConkey agar plates following the standard bacteriological protocols. It was incubated aerobically at 35-37 °C for 24-48 h. Cultural characteristics and series of biochemical tests were used for the identification of isolates to species level based on the standard bacteriological protocols.
RESULTS
A hospital-based cross-sectional study has shown that significant bacteriuria was found in 11/74 (14.9, 95% CI =8.2-24.7) patients. The prevalence among females 6/32 (18.75%) was higher among males 5/42 (11.9%) without significant association (COR = 2.09, 95% CI = 1.04-8.45, P = 0.253). Urinary tract infection was higher in the age group of 35-49 years old (19.3%). Age was statistically significant and stronger independent associated risk factor with crude odds ratio = 3.67, 95% CI = 2.89-20.07 and P = 0.003, respectively. The most prevalent bacteria isolates were Escherichia coli 2(18.2%), Staphylococcus aureus 2(18.2%), Acinetobacter spp. 2(18.2%), Enterococcus spp. 2(18.2%), Coagulase-negative Staphylococci 2(18.2%) followed by Porteus mirabilis 1(9.1%). The majority (80%) of Gram-negative bacteria were resistant to ciprofloxacin, chloramphenicol, and trimethoprim/sulfamethoxazole. Simultaneously, the multidrug-resistant bacterial isolates accounts for 82% among tested kidney allograft recipients.
CONCLUSIONS
In conclusion, the overall prevalence of urinary tract infection in the study participants was relatively low with a prevalence of 14.9%. Majority of the study participants were asymptomatic and a higher percentage of females were involved. The multidrug-resistant bacterial isolates in the present study account for 82%.

Identifiants

pubmed: 31366333
doi: 10.1186/s12882-019-1485-9
pii: 10.1186/s12882-019-1485-9
pmc: PMC6668100
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

289

Références

Kidney Int. 2010 Oct;78(8):719-21
pubmed: 20877371
Infect Drug Resist. 2018 May 14;11:707-715
pubmed: 29785131
Transpl Infect Dis. 2018 Apr;20(2):e12828
pubmed: 29272071
Transplant Proc. 2006 Oct;38(8):2414-5
pubmed: 17097953
Transplant Proc. 2015 Jul-Aug;47(6):1808-12
pubmed: 26293055
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Transplant Proc. 2008 Jul-Aug;40(6):1873-6
pubmed: 18675076
PLoS One. 2015 Dec 10;10(12):e0144266
pubmed: 26657128
Iran J Microbiol. 2014 Apr;6(2):74-8
pubmed: 25705355
Am J Kidney Dis. 2004 Aug;44(2):353-62
pubmed: 15264195
Am J Transplant. 2007 Apr;7(4):899-907
pubmed: 17286620
Am J Transplant. 2016 Oct;16(10):2943-2953
pubmed: 27088545
Nat Clin Pract Nephrol. 2008 May;4(5):252-64
pubmed: 18334970
Rev Soc Bras Med Trop. 2015 May-Jun;48(3):285-90
pubmed: 26108006
Clin Transplant. 2005 Apr;19(2):230-5
pubmed: 15740560
Acta Med Port. 2014 May-Jun;27(3):364-71
pubmed: 25017349
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Clin Infect Dis. 2005 Mar 1;40(5):643-54
pubmed: 15714408
Eur J Clin Invest. 2008 Oct;38 Suppl 2:58-65
pubmed: 18826483
Clin Transplant. 2014 Jun;28(6):683-90
pubmed: 24654771
J Family Med Prim Care. 2016 Jul-Sep;5(3):611-614
pubmed: 28217592
Transpl Int. 2005 Feb;18(2):177-85
pubmed: 15691270
Transplantation. 2006 Jun 27;81(12):1653-7
pubmed: 16794530
Transplant Proc. 2016 Jun;48(5):1580-9
pubmed: 27496451
Clin Microbiol Infect. 2015 Dec;21(12):1104.e1-8
pubmed: 26235196
Nephrol Dial Transplant. 2014 Feb;29(2):260-2
pubmed: 24203811
Kidney Int. 2010 Oct;78(8):774-81
pubmed: 20720526
Clin Transplant. 2019 Sep;33(9):e13507
pubmed: 30793386
Transpl Infect Dis. 2012 Dec;14(6):595-603
pubmed: 22650416
Ren Fail. 2011;33(4):405-10
pubmed: 21529269
J Nephrol. 2019 Aug;32(4):661-668
pubmed: 30701457
J Nephrol. 2019 Oct;32(5):751-761
pubmed: 30689126
J Transplant. 2015;2015:854640
pubmed: 25810918
Transplant Proc. 2017 Nov;49(9):2070-2075
pubmed: 29149963
Ann Transplant. 2017 Jun 30;22:402-408
pubmed: 28663538
J Glob Infect Dis. 2011 Oct;3(4):383-9
pubmed: 22224004
Transpl Int. 2016 Feb;29(2):241-52
pubmed: 26563524
Am J Transplant. 2013 Mar;13 Suppl 4:327-36
pubmed: 23465025

Auteurs

Teklehaimanot Kiros (T)

Department of Medical Microbiology, College of Medicine and Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia. tkt0932@gmail.com.

Daniel Asrat (D)

Department of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Zeleke Ayenew (Z)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Estifanos Tsige (E)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH